¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Syndrome, giant platelet"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • fetal alcohol syndrome
    žƾËÄÚ¿ÃÁõÈıº
  • fetal distress syndrome
    žưï¶õÁõÈıº
  • fetal hydantoin syndrome
    žÆÈ÷´ÜÅäÀÎÁõÈıº
  • fibromyalgia syndrome
    ¼¶À¯±ÙÅëÁõÈıº
  • Fisher syndrome
    ÇǼÅÁõÈıº
  • fish-odor syndrome
    ¹°°í±âÇâÁõÈıº
  • failed back surgery syndrome
    ôÃß¼ö¼úÈÄ¿äÅëÁõÈıº
  • floppy infant syndrome
    Àú±äÀ念¾ÆÁõÈıº
  • false memory syndrome
    °ÅÁþ±â¾ïÁõÈıº
  • fragile X syndrome
    ¿©¸°XÁõÈıº
  • gastrointestinal syndrome
    À§Àå°üÁõÈıº
  • gay bowel syndrome
    µ¿¼º¾ÖÀÚâÀÚÁõÈıº
  • general adaptation syndrome
    Àü½Å¼øÀÀÁõÈıº
  • Goodpasture¡¯s syndrome
    ±ÂÆÄ½ºÃ³ÁõÈıº
  • gray syndrome
    ȸ»öÁõÈıº
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • fertile eunuch syndrome
    °¡ÀÓ°íÀÚÁõÈıº
  • fetal alcohol syndrome
    žƾËÄÚ¿ÃÁõÈıº
  • fetal distress syndrome
    žưíÅëÁõÈıº, žÆÀý¹Ú°¡»çÁõÈıº
  • fish-eye syndrome
    ¹°°í±â´«ÁõÈıº
  • fish-odor syndrome
    ¹°°í±âÇâÁõÈıº
  • floppy infant syndrome
    Àú±äÀ徯ÁõÈıº, ±äÀåÀúÇÏ¿µ¾ÆÁõÈıº
  • fragile X syndrome
    À¯¾à¿¢½ºÁõÈıº
  • gastrointestinal syndrome
    À§Àå°üÁõÈıº
  • general adaptation syndrome
    Àü½Å¼øÀÀÁõÈıº
  • green nail syndrome
    ³ì»ö¼Õ¹ßÅéÁõÈıº
  • hematopoietic syndrome
    Á¶Ç÷ÁõÈıº
  • hemolytic-uremic syndrome
    ¿ëÇ÷¿äµ¶ÁõÈıº
  • hemopleuropneumonic syndrome
    Ç÷¾×°¡½¿¸·ÇãÆÄÁõÈıº
  • hereditary adrenogenital syndrome
    À¯ÀüºÎ½Å¼º±âÁõÈıº
  • heredofamilial hypothalamohypophyseal syndrome
    À¯Àü°¡Á·½Ã»óÇϺγúÇϼöüÁõÈıº
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • CREST syndrome
    Å©·¹½ºÆ® ÁõÈıº
  • CRST(Calcinosis, Raynauds phenomenon, Sclerodactyly, Telangiectasia) syndrome
    CRST ÁõÈıº.
  • Cestans syndrome
    ¼¼½ºÅºÁõÈıº.
  • Chandlers syndrome
    îµé·¯ÁõÈıº
  • Charcot-Wilbrand syndrome
    »þ¸£ÄÚ-ºôºê¶õµåÁõÈıº.
  • Charcots syndrome
    »þ¸£ÄÚÁõÈıº.
  • Charlins syndrome
    »þ¸¦·©ÁõÈıº.
  • Chauffard-Still syndrome
    ¼îÆÄ¸£-½ºÆ¿ÁõÈıº.
  • Chediak-Higashi syndrome
    ¼¼µð¾ÆÅ©-È÷°¡½Ã ÁõÈıº
  • Chediak-Higashi syndrome
    ¼¼µð¾ÆÅ©-È÷°¡½ÃÁõÈıº.
  • Chilaiditis syndrome
    ų¶óÀ̵ðƼÁõÈıº.
  • Chronic fatigue syndrome
    ¸¸¼ºÇÇ·Î ÁõÈıº
  • Churg-Strauss syndrome
    Ãʱ×-½ºÅä¶ó¿ì½º ÁõÈıº
  • Cockayne syndrome
    ÄÚÄÉÀÎ ÁõÈıº(~ ñøý¦ÏØ)
  • Cockaynes syndrome
    ÄÚÄÉÀÎ ÁõÈıº
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • absent pulmonary valve syndrome
    Æóµ¿¸ÆÆÇ°á¿©Áõ.
  • absent pulmonary valve syndrome
    Æóµ¿¸ÆÆÇ°á¿©Áõ.
  • absent testes syndrome
    °íȯ°á¿©ÁõÈıº
  • abstinence syndrome
    ±Ý´ÜÁõÈıº(Ð×Ó¨ñøý¦ÏØ).
  • acid aspiration syndrome
    À§»ê ÈíÀÔ ÁõÈıº
  • acquired immune deficiency syndrome
    ÈÄõ¼º ¸é¿ª°áÇÌ ÁõÈıº
  • acquired immune deficiency syndrome
    ÈÄõ¼º ¸é¿ª°áÇÌÁõÈıº(ý­ô¸àõ Øóæ¹ÌÀù¹ñøý¦ÏØ)
  • acquired immunodeficiency syndrome
    ÈÄõ¼º ¸é¿ª°áÇÌ ÁõÈıº
  • acquired immunodeficiency syndrome
    ÈÄõ¼º¸é¿ª°áÇÌÁõ
  • acquired immunodeficiency syndrome (AIDS)
    ÈÄõ¼º¸é¿ª°áÇÌÁõ(Èıº)
  • acquired immunodeficiency syndrome(AIDS)
    ÈÄõ¼º ¸é¿ª°áÇÌ ÁõÈıº
  • acute brain syndrome
    ±Þ¼º ³úÁõÈıº(¡­Òàñøý¦ÏØ).
  • acute fulminating meningococcemia ; Waterhouse Friderichsen syndrome
    ±Þ¼º Àü°Ý¼º ¼ö¸·±¸±Õ±ÕÇ÷Áõ.
  • acute radiation syndrome
    ±Þ¼º¹æ»ç¼±ÁõÈıº
  • acute radiation syndrome
    ±Þ¼º¹æ»ç¼±ÁõÈıº(¡­Û¯ÞÒàÊñøý¦ÏØ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 10
MGG May-Grunwald-Giemsa [staining]; molecular and general genetics; mouse gammaglobulin; multinucleated ...
RGC radio-gas chromatography; remnant gastric cancer; retinal ganglion cell; right giant cell
SGCA subependymal giant cell astrocytoma
HELLP hemolysis, elevated liver enzymes, and low platelet count [syndrome]
PAC papular acrodermatitis of childhood; parent-adult-child; pericarditis-arthropathy-camptodactyly [syn...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 10
PDGFR Platelet Derived Growth Factor Receptors
PDW Platelet Distribution Width
PECAM-1, CD31 Platelet Endothelial Cell Adhesion Molecule-1
PF 3 Platelet Factor 3
PF-4 Platelet Factor 4
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Crouzon syndrome
    Å©·ÎÁ¸ ÁõÈıº, Å©·çÁ¸ ÁõÈıº
    µÎ°³ ¾È¸é À̰ñÁõ, Å©·çÁ¸¾¾ Áúȯ, ¿¡ÆÛÆ® Å©·çÁ¸¾¾ ÁõÈıº µîÀÌ µ¿ÀǾî·Î ¾²À̰í ÀÖ´Ù. µÎ°³ ±âÇü, ¾È¸é Áß¾ÓºÎÀÇ Çü¼º ºÎÀü ¹× ¾èÀº ¾È¿Í·Î ÀÎÇÑ ¾È±¸ µ¹ÃâÁõÀ» Ư¡À¸·Î ÇÑ´Ù.
  • CRST syndrome
    CRST ÁõÈıº
    Calcinosis, Raynauds
  • Cushing's syndrome
    Äí½Ì ÁõÈıº
    1. ºÎ½Å ÇÇÁúÀÇ Á¾¾ç ¶Ç´Â °úÇÕ¼º¿¡ ÀÇÇØ ÄÚ¸£Æ¼Á¹ÀÌ Áö³ªÄ¡°Ô ºÐºñµÊÀ¸·Î½á »ý±ä´Ù. º¸¸§´Þ°ú °°Àº ¾ó±¼ ¸ð½À, ¾È¸é È«Á¶, ÆÄÆÈ·ÎÇü ºñ¸¸, ¼±Ãµ¼º ÇǺμ±¿°, °íÇ÷¾Ð µîÀÌ Æ¯Â¡ÀÖ´Â Áõ»óÀÌ´Ù. 2. ºÎ½Å ÇÇÁú¿¡¼­ ´çÁú ÄÚ¸£Æ¼ÄÚÀ̵尡 °ú´ÙÇÏ°Ô ºÐºñµÇ´Â º´. 1932³â ¹Ì±¹ÀÇ H. Äí½ÌÀÌ ¹ß°ßÇÏ¿´´Ù. ºÎ½Å ÇÇÁú¿¡ ¾Ç¼º ¶Ç´Â ¾ç¼ºÀÇ Á¾¾çÀÌ »ý±â°Å³ª ºÎ½Å ÇÇÁú ±× ÀÚü°¡ °ú´ÙÇÏ°Ô Áõ½ÄÇÏ´Â °æ¿ì¿¡ ³ªÅ¸³­´Ù. ºñ±³Àû µå¹® Áõ»óÀ¸·Î, 10¡­20´ë¿¡ ¸¹°í ¿©ÀÚ¿¡°Ô ¸¹´Ù. Áõ¼¼·Î´Â °íÇ÷¾Ð, ¸¸¿ù»ó ¾È¸ð
  • Cushingoid syndrome
    Äí½Ì¾ç ÁõÈıº
  • cystic duct syndrome
    ´ã³¶ °ü ÁõÈıº
  • de Clerambault syndrome
    ²ô·¹¶ûº¸¿À ÁõÈıº
  • de-toni-Debre-Fanconi syndrome
    µð-Åä´Ï-µðºê¸®-ÆÇÄÚ´Ï ÁõÈıº
  • Defibrillation syndrome
    Å»¼¶À¯¼Ò ÁõÈıº
  • deficient antibody syndrome
    Ç×ü °áÇÌ ÁõÈıº
  • deficit syndrome
    °áÇÌ ÁõÈıº
  • Demons-Meigs' syndrome
    µ¥¸ó½º-¸Þ±×½º ÁõÈıº
    ³­¼Ò ¼¶À¯Á¾À¸·Î È÷½ºÅ¸¹Î¿¡ ÀÇÇÑ ¾Æ³ªÇʶô½Ã Áõ»ó. ¼ö´ë»ç¿Í ±³Áú°èÀÇ º´º¯ ¹× Á¾¾çÀÇ È£¸£¸ó ÀÛ¿ë¿¡ ÀÇÇØ º¹¼ö¿Í Èä¼ö°¡ º´¹ßÇÑ´Ù.
  • denial-of-deficit syndrome
    °áÇÌ ºÎÁ¤ ÁõÈıº
  • Denny-Brown's syndrome
    µ¥´Ï-ºê¶ó¿î ÁõÈıº
    ³»°æµ¿¸Æ Æó»öÁõÀ̶ó°íµµ Çϸç, ºñ±³Àû ÀþÀº Ãþ¿¡ ¸¹Àº º´À¸·Î, °£Áú ºñ½ÁÇÑ ¹ßÀÛ, °¡º­¿î ¾ð¾î ÀåÇØ, ¹Ý½Å ºÒ¼ö µîÀÇ Áõ»óÀÌ Æ¯Â¡Àε¥, ³úµ¿¸Æ ÃÔ¿µÀ¸·Î °æµ¿¸ÆÀÇ Æó»öÀ» Áõ¸íÇÒ ¼ö ÀÖ´Ù.
  • dermatorheumatismal syndrome
    ÇǺΠ·ù¸¶Æ¼½º ÁõÈıº
  • Devies syndrome
    µ¥ºò ÁõÈıº
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
ankyloglossia superior syndrome <syndrome> A congenital condition in which the tongue adheres to the hard palate; no evidence of genetic factors.
(05 Mar 2000)
anorectal syndrome <syndrome> Soreness, burning, itching, or other irritation of the rectum together with redness about the anus, and sometimes accompanied by diarrhoea, occurring as a toxic effect of the oral administration of certain broad spectrum antibiotics.
(05 Mar 2000)
anterior chamber cleavage syndrome <syndrome> A congenital disorder originating from faulty separation of embryonic structures; it results in bilateral central corneal opacities, with an anterior ring attachment of the iridic pupillary border and anterior polar cataracts; associated with short-limbed dwarfism; autosomal dominant inheritance.
See: iridocorneal endothelial syndrome.
Synonym: Peters' anomaly.
(05 Mar 2000)
anterior compartment syndrome <syndrome> Rapid swelling, increased tension, pain, and ischemic necrosis of the muscles of the anterior tibial compartment of the leg, often following excessive exertion.
(12 Dec 1998)
anterior tibial compartment syndrome <syndrome> Ischemic necrosis of the muscles of the anterior tibial compartment of the leg, presumed due to compression of arteries by swollen muscles following unaccustomed exertion.
(05 Mar 2000)
antibody deficiency syndrome <syndrome> Any of a group of disorders associated with a defective antibody production due to defects in the B-type lymphocyte system or in T-type lymphocytes; chief manifestation is an increased susceptibility to infection by various microorganisms.
See: agammaglobulinaemia, hypogammaglobulinaemia, immunodeficiency.
Synonym: antibody deficiency disease.
(05 Mar 2000)
antiphospholipid antibody syndrome <syndrome> An immune disorder characterised by the presence of abnormal antibodies in the blood associated with certain medical conditions including abnormal blood clotting, migraine headaches, premature miscarriage, and low blood platelet counts (thrombocytopenia).
(12 Dec 1998)
antiphospholipid syndrome <immunology, syndrome> An uncommon disorder that is characterised by hypercoagulability due to the presence of antibodies against phospholipids.
These patients exhibit a tendency for recurrent and life-threatening thrombosis and embolic events (for example stroke). Individuals with antiphospholipid syndrome also have an increased tendency toward deep venous thrombosis, myocardial infarction and spontaneous abortions in females.
Antiphospholipid syndrome may be seen by itself or in association with other autoimmune illnesses (for example lupus) or with some infections.
Treatment includes long-term heparin and warfarin.
(13 Jan 1998)
Anton's syndrome <syndrome> In cortical blindness, lack of awareness of being blind.
(05 Mar 2000)
anxiety syndrome <syndrome> The constellation of autonomic nervous system signs and symptoms accompanying the apprehension of danger and dread.
See: anxiety.
(05 Mar 2000)
aortic arch syndrome <syndrome> Aortic arch syndrome, also referred to by many as vertebral-basilar artery disease, carotid artery occlusive syndrome and subclavian steal syndrome is characterised by a constellation of signs and symptoms which occur secondary to abnormalities in the major arteries which extend off of the aortic arch. These abnormalities are structural and most often secondary to the effects of atherosclerosis, blood clots, trauma or a congenital abnormality. Symptoms of this condition include various neurologic symptoms, reduction in pulse and changes in blood pressure.
(27 Sep 1997)
apallic syndrome Diffuse, bilateral cerebral cortical degeneration caused by head injury, anoxia, or encephalitis, a state of persistent unresponsiveness, such as akinetic mutism, caused by brain damage.
See: vegetative.
Synonym: apallic syndrome, apallic.
(05 Mar 2000)
Apert's syndrome <paediatrics> A usually inherited disorder characterised by premature closing of the cranial suture lines resulting in a peaked shaped head and abnormal facial appearance.
Since it is usually autosomal dominant one or both parents also have the disorder. Surgery is used to correct skull and facial abnormalities.
Inheritance: autosomal dominant.
(29 Dec 1997)
Apert syndrome <syndrome> Apert (1906) defined a syndrome characterised by skull malformation (acrocephaly of brachysphenocephalic type) due to the premature closure of the cranial sutures and syndactyly of the hands and feet of a special type (complete distal fusion with a tendency to fusion also of the bony structures). The hand, when all the fingers are webbed, has been compared to a spoon and, when the thumb is free, to an obstetric hand.
Two clinical categories are distinguished, a 'typical' acrocephalosyndactyly, to which Apert's name is appropriately applied and other forms lumped together as 'atypical' acrocephalosyndactyly.
The feature distinguishing the two types is a middigital hand mass with a single nail common to digits 2-4, found in Apert syndrome and lacking in the others. A frequency of Apert syndrome of 1 in 160,000 births is estimated.
Evidence suggests that Apert syndrome results from mutations in the gene encoding fibroblast growth factor receptor-2.
Progressive synostosis occurs in the feet, hands, carpus, tarsus, cervical vertebrae, and skull, and proposed 'progressive synosteosis with syndactyly' is possibly a more appropriate designation.
Clinical features: flat facies, shallow orbits, hypertelorism, narrow palate, craniosynostosis, brachysphenocephalic acrocephaly, syndactyly, broad thumb, broad great toe, single nail digits 2-4, variable mental retardation, corpus callosum and/or limbic malformations, fused cervical vertebrae.
A skull X-ray can confirm the diagnosis. Treatment is surgical.
Inheritance: autosomal dominant, paternal age effect.
(05 Aug 1998)
Argonz-Del Castillo syndrome <syndrome> Unphysiological lactation and amenorrhoea not following pregnancy characterised by hyperprolactinaemia and a pituitary adenoma.
Synonym: Argonz-Del Castillo syndrome.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 10
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 10
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 10
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 10
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 10
ÅëÇÕ°Ë»ö ¿Ï·á